Chemical ligation and cleavage on solid support facilitate recombinant peptide purification

Area of Science:

• Biotechnology and Pharmaceutical Sciences
• Chemical Biology and Peptide Synthesis

Background:

• Recombinant peptide production offers an alternative to traditional synthesis and extraction.
• Inefficient purification methods create heterogeneity and limit the utility of recombinant peptides.
• Current purification often relies on expensive High-Performance Liquid Chromatography (HPLC).

Purpose of the Study:

• To develop an efficient and cost-effective purification strategy for recombinant therapeutic peptides.
• To demonstrate the applicability of the method for producing Glucagon-Like Peptide-1 (GLP-1(7-37)) for type-2 diabetes.
• To establish a versatile method for preparing isotopically labeled peptide samples for Nuclear Magnetic Resonance (NMR) studies.

Main Methods:

• A combined strategy utilizing native chemical ligation and chemical cleavage on a solid support.
• Solid-phase synthesis and purification of the recombinant peptide GLP-1(7-37).
• Avoidance of traditional HPLC purification steps.

Main Results:

• High yield and purity of the therapeutic peptide GLP-1(7-37) were achieved.
• The purification process was effective without the need for expensive HPLC.
• The method proved suitable for generating isotopically labeled peptide samples for NMR analysis.

Conclusions:

• The combined strategy of chemical ligation and solid-phase cleavage is a viable alternative for recombinant peptide purification.
• This approach significantly improves the production efficiency and reduces costs for recombinant pharmaceutical peptides.
• The method holds promise for the scalable production of therapeutic peptides and specialized NMR samples.